BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Long-Term Debt Issuances (2022)

Updated

BioXcel Therapeutics (BTAIQ) posted Long-Term Debt Issuances of $98.6 million for FY2022.

Analysis

BioXcel Therapeutics (BTAIQ) Long-Term Debt Issuances (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 30.00 Mn
API Access

BioXcel Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY